EGFR and non-small cell lung carcinoma: Our study helps better understand the clinical characteristics of compound EGFR mutations and emphasizes the importance of determining the specific types of EGFR mutations, which can potentially direct prognosis prediction and provide personalized treatments to NSCLC patients.